On the basis of the reported expression of PD-L2 on malignant breast epithelia27,28 and its high affinity for PD-1,25 we hypothesized that elevated PD-L2 is associated with unfavorable outcome in locoregional ER+ breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.